Researchers from Radiology, Radiation Oncology and Urology at Beaumont Health studied the relationship between benign prostatic hyperplasia, or BPH, and prostate cancer in 405 men by quantitatively looking at different parts of prostate tissue on MRI. They found that patients with an enlarged prostate appear to have lower odds of signiﬁcant prostate cancer. The results were recently published in The Prostate.
“People often confuse an enlarged prostate gland with cancer given their symptoms and believe increased size is due to abnormal growth,” said researcher Dr. Kiran Nandalur, vice chief of Diagnostic Radiology and Molecular Imaging, Beaumont Hospital, Royal Oak. “Prostate MRI, which is noninvasive imaging without radiation, is a powerful radiology test to look at the different anatomy of the prostate, speciﬁcally differentiating the central and outer aspects of the prostate gland, and also for underlying cancer.”
BPH is very common and often considered a nuisance of aging as many men have uncomfortable urinary symptoms such as the frequent need to urinate, often at night, or weak ﬂow of urine. This is because the central part of the prostate enlarges with time from BPH and can obstruct urine leaving the bladder. Men often experience these symptoms and are concerned they have an underlying abnormality. The greatest fear is prostate cancer, which is the second most common cancer among men. When patients are told their symptoms are likely from an enlarged prostate from BPH, which is benign, they often still have anxiety whether this condition may increase their chances of cancer.
“Previous studies are unclear whether BPH increases, decreases, or has no effect on prostate cancer risk,” said Dr. Nandalur. “Our ﬁndings should help reduce possible fears about signiﬁcant prostate cancer when diagnosed with BPH, which is often misunderstood by the public. According to the studied MRI data, patients with BPH appear to have a potential protective factor against prostate cancer. The results may also explain why previous data has shown commonly prescribed drugs used to treat BPH may result in higher grade prostate cancer. However, individualized management of a patient’s BPH is best determined after consultation with their physician.”Back To Top
Enlarged Prostate Lowers Chance of Significant Prostate Cancer. Appl Rad Oncol.